Conditioned Medium From Reactive Astrocytes Inhibits Proliferation, Resistance, and Migration of p53‐Mutant Glioblastoma Spheroid Through GLI‐1 Downregulation

ABSTRACT Glioblastoma (GBM) aggressiveness is partly driven by the reactivation of signaling pathways such as Sonic hedgehog (SHH) and the interaction with its microenvironment. SHH pathway activation is one of the phenomena behind the glial transformation in response to tumor growth. The reactivation of the SHH signaling cascade during GBM–astrocyte interaction is highly relevant to understanding the mechanisms used by the tumor to modulate the adjacent stroma. The role of reactive astrocytes considering SHH signaling during GBM progression is investigated using a 3D in vitro model. T98G GBM spheroids displayed significant downregulation of SHH (61.4 ± 9.3%), GLI‐1 (6.5 ± 3.7%), Ki‐67 (33.7 ± 8.1%), and mutant MTp53 (21.3 ± 10.6%) compared to the CONTROL group when incubated with conditioned medium of reactive astrocytes (CM‐AST). The SHH pathway inhibitor, GANT‐61, significantly reduced previous markers (SHH = 43.0 ± 12.1%; GLI‐1 = 9.5 ± 3.4%; Ki‐67 = 31.9 ± 4.6%; MTp53 = 6.5 ± 7.5%) compared to the CONTROL, and a synergistic effect could be observed between GANT‐61 and CM‐AST. The volume (2.0 ± 0.2 × 10 7 µm³), cell viability (80.4 ± 3.2%), and migration (41 ± 10%) of GBM spheroids were significantly reduced in the presence of GANT‐61 and CM‐AST when compared to CM‐AST after 72 h (volume = 2.3 ± 0.4 × 10 7 µm³; viability = 92.2 ± 6.5%; migration = 102.5 ± 14.6%). Results demonstrated that factors released by reactive astrocytes promoted a neuroprotective effect preventing GBM progression using a 3D in vitro model potentiated by SHH pathway inhibition.